A review on diverse neurological disorders : pathophysiology, molecular mechanisms, and therapeutics /
According to World Health Organization (WHO) one billion people worldwide are affected by one of the thousands of neurological disorders, including epilepsy, Alzheimer disease, strokes, and headaches.Neurological disorders also include brain injuries, neuroinfections, multiple sclerosis and Parkinso...
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | eBook |
| Language: | English |
| Published: |
London :
Academic Press,
2024.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Front Cover
- A REVIEW ON DIVERSE NEUROLOGICAL DISORDERS
- A REVIEW ON DIVERSE NEUROLOGICAL DISORDERS: PATHOPHYSIOLOGY, MOLECULAR MECHANISMS, AND THERAPEUTICS
- Copyright
- Dedication
- Contents
- List of contributors
- Preface
- A
- Overview and introduction
- 1
- Epidemiology and risk factors of mental disorders
- 1. Introduction
- 2. Risk factor of mental disorder
- 2.1 Anxiety disorders
- 3. Depression
- 4. Bipolar disorder
- 5. Posttraumatic stress disorder
- 6. Schizophrenia
- 7. Eating disorder
- 8. Disruptive behavior and dissocial disorders
- 9. Neurodevelopmental disorders
- 10. Obsessive compulsion disorder
- 11. Dementia
- 12. Panic disorders
- 12.1 Insomnia
- 13. Delirium
- 14. Paranoid personality disorder
- 15. Alzheimer's disease
- 16. Parkinson's disease
- 17. Mood disorder
- 18. Phobia
- 19. Autism
- 20. Current status of mental disorders worldwide
- 21. Prevalence of mental disorder among the different regions of the world
- 21.1 Who is at risk?
- 22. Health systems and social support
- References
- B Diverse neurological diseases: Bacterial, fungal, virus, and parasitic infections
- 2
- Unlocking the intricacies: Bacterial meningitis's impact on neurological function
- 1. Introduction
- 2. Meningitis
- 3. Bacterial meningitis
- 4. Etiology
- 5. Epidemiology
- 6. Acute meningitis-Children
- 6.1 Newborns
- 6.2 1 month to 2years
- 6.3 2-17years
- 6.4 Acute meningitis-Adults
- 6.4.1 19-60years
- 6.4.2 Age 60years
- 6.5 Signs and symptoms
- 6.5.1 Newborns
- 6.5.2 Children aged 1-4years
- 6.5.3 Older children and adults
- 7. Pathogenesis of bacterial meningitis common stages and mechanisms
- 7.1 Streptococcus pneumoniae meningitis
- 8. Invasion and spread of bacteria
- 9. Translocation of bacteria into the CNS
- 10. Inflammation and immune activation in the brain.
- 10.1 Meningococcal meningitis
- 11. Invasion and spread of bacteria
- 12. Translocation of bacteria into the CNS
- 13. Inflammation and immune activation in the brain
- 13.1 Group B Streptococcus meningitis
- 14. Invasion and spread of bacteria
- 15. Translocation of bacteria into the CNS
- 16. Inflammation and immune activation in the brain
- 16.1 Streptococcus suis meningitis
- 17. Invasion and spread of bacteria
- 18. Translocation of bacteria into the CNS
- 19. Inflammation and immune activation in the brain
- 19.1 Escherichia coli K1-induced neonatal meningitis
- 20. Invasion and spread of bacteria
- 21. Translocation of bacteria into the CNS
- 22. Inflammation and immune activation in the brain
- 23. Symptoms and signs
- 24. Neuronal damage
- 25. Clinical features and diagnosis
- 26. Treatment
- 27. Prognosis
- 28. Surveillance
- 29. Conclusion
- References
- 3
- An overview on helminthic infections of central nervous system in humans
- 1. Introduction
- 2. Echinococcosis: Echinococcus spp.
- 2.1 Route of infection and life cycle of the parasite
- 2.2 Pathophysiology/immunopathology
- 2.3 Diagnosis and treatment
- 2.4 Challenges
- 3. Neuroschistosomiasis: Schistosoma japonicum, Schistosoma mekongi
- 3.1 Disease background
- 3.2 Route of infection and life cycle of the parasite
- 3.3 Epidemiology
- 3.4 Clinical presentation, diagnosis, and treatment
- 3.5 Immunopathology
- 3.6 Challenges
- 4. Neurocysticercosis: Taenia solium
- 4.1 Disease background
- 4.2 Route of infection and life cycle of the parasite
- 4.3 Epidemiology
- 4.4 Clinical presentation, diagnosis, and treatment
- 4.5 Immunopathology
- 4.6 Challenges
- 5. Angiostrongyliasis-Angiostrongylus cantonensis
- 5.1 Disease background
- 5.2 Route of infection and life cycle of the parasite
- 5.3 Epidemiology.
- 5.4 Clinical presentation, diagnosis, and treatment
- 5.5 Immunopathology
- 5.6 Challenges
- 6. Sparganosis: Spirometramansoni
- 6.1 Disease background
- 6.2 Route of infection and life cycle of the parasite
- 6.3 Epidemiology
- 6.4 Clinical presentation, diagnosis, and treatments
- 6.5 Immunopathology
- 6.6 Challenges
- 7. Paragonimiasis: Paragonimus westermani
- 7.1 Disease background
- 7.2 Route of infection and life cycle of the parasite
- 7.3 Epidemiology
- 7.4 Clinical presentation, diagnosis, and treatment
- 7.5 Immunopathology
- 7.6 Challenges
- 8. Coenurosis: Tapeworm larvae (Taenia species)
- 8.1 Disease background
- 8.2 Route of infection and life cycle of the parasite
- 8.3 Epidemiology
- 8.4 Clinical symptoms, diagnosis, and treatments
- 8.5 Immunopathology
- 8.6 Challenges
- 9. Neurognathostomiasis: Gnathostoma spp.
- 9.1 Disease background
- 9.2 Route of infection and life cycle of the parasite
- 9.3 Epidemiology
- 9.4 Clinical presentation, diagnosis, and treatment
- 9.5 Challenges
- 10. Neurostrongyloidiasis: Strongyloidesstercoralis
- 10.1 Disease background
- 10.2 Route of infection and life cycle of the parasite
- 10.3 Epidemiology
- 10.4 Clinical presentation, diagnosis, and treatment
- 10.5 Challenges
- 11. Onchocerciasis: Onchocerca volvulus
- 11.1 Disease background
- 11.2 Route of infection and life cycle of the parasite
- 11.3 Epidemiology
- 11.4 Clinical presentation, diagnosis, and treatments
- 11.5 Challenges
- 12. Conclusion
- References
- 4
- Helminthic infections of the central nervous system
- 1. Introduction
- 2. CNS diseases caused by cestodes
- 2.1 Neurocysticercosis
- 2.1.1 Epidemiology
- 2.1.2 Genetic predisposition
- 2.1.3 Pathophysiology
- 2.1.3.1 Typical life cycle of Taenia solium
- 2.1.4 Clinical features
- 2.1.5 Parenchymal NCC.
- 2.1.6 Extraparenchymal NCC
- 2.1.7 Diagnosis
- 2.1.7.1 Neuroimaging
- 2.1.7.2 Immunological assays
- 2.1.7.3 Stool microscopy
- 2.1.8 Treatment
- 2.1.9 Prevention
- 2.2 Cerebral echinococcosis
- 2.2.1 Introduction
- 2.2.2 Epidemiology
- 2.2.3 Pathophysiology
- 2.2.4 Clinical features
- 2.2.5 Diagnosis
- 2.2.6 Treatment
- 2.2.7 Complications and recurrence
- 3. CNS diseases caused by nematodes
- 3.1 Angiostrongyliasis
- 3.2 Gnathostomiasis
- 3.3 Strongyloidiasis
- 3.4 Neurotoxocariosis
- 3.5 Neurotrichinosis
- 4. CNS diseases caused by trematodes
- 4.1 Schistosomiasis
- 4.2 Paragonimiasis
- 5. Conclusion
- References
- 5
- Tuberculosis of the central nervous system: Pathogenicity and molecular mechanism
- 1. Introduction
- 1.1 Tuberculosis
- 1.2 Active and latent tuberculosis
- 1.3 Pulmonary and extrapulmonary tuberculosis
- 1.4 Molecular mechanism and pathogenicity
- 2. Available therapies and challenges
- 3. Tuberculosis of the central nervous system
- 3.1 Clinical presentation
- 3.2 Mechanism of infection
- 3.3 Tuberculous meningitis
- 3.4 Diagnosis and therapeutic progress for tuberculosis of the central nervous system
- 4. Future prospects
- 5. Concluding remarks
- References
- 6
- Tuberculosis of central nervous system
- 1. Introduction
- 2. Burden of the disease
- 3. Pathogenesis
- 4. Forms of the disease
- 4.1 Brain and its coverings
- 4.1.1 Tuberculous meningitis
- 4.1.2 Tuberculous pachymeningitis
- 4.1.3 Tuberculoma
- 4.1.4 Tuberculous encephalopathy
- 4.2 Osseous and nonosseous spinal tuberculosis
- 4.2.1 Pott's disease
- 4.2.2 Tuberculous myelitis
- 4.2.3 Tuberculous arachnoiditis and radiculomyelopathy
- 5. Diagnosis
- 5.1 CSF examination
- 5.1.1 Routine examination
- 5.1.2 Microbiological testing
- 5.1.2.1 Smear and culture of acid-fast bacteria.
- 5.1.2.2 Nucleic acid amplification test
- 5.2 Radiographic imaging
- 6. Management
- 6.1 Antituberculous therapy
- 6.1.1 Drug-sensitive tuberculosis
- 6.1.2 Drug-resistant tuberculosis
- 6.1.3 Use of adjuvant steroids
- 6.1.3.1 Shortened regimen
- 6.1.4 Treatment in immunocompromized hosts
- 7. Complications
- 7.1 Raised intracranial pressure and hydrocephalus
- 7.2 Vasculopathy and stroke
- 7.3 Optochiasmatic arachnoiditis
- 7.4 Seizures
- 7.5 Hyponatremia
- 8. Paradoxical reaction and IRIS
- 9. Conclusion
- References
- Further reading
- 7
- An overview on tetanus, diphtheria, and diverse bacterial infections of the CNS
- 1. Introduction
- 2. Tetanus
- 2.1 Pathogenesis
- 2.2 Clinical manifestations
- 2.3 Diagnosis
- 2.4 Management
- 2.4.1 Prevention
- 2.4.2 Treatment of infection
- 3. Diphtheria
- 3.1 Epidemiology
- 3.2 Pathogenesis
- 3.3 Clinical manifestations
- 3.4 Diagnosis
- 3.5 Management
- 4. Other bacterial infections of the CNS
- 4.1 Bacterial meningitis
- 4.2 Spinal epidural abscess
- 4.3 Rickettsial infection
- 4.4 Subdural empyema
- 4.5 Brain abscess
- 4.6 Neurosyphilis
- 4.7 CNS tuberculosis
- 5. Conclusion
- References
- Further reading
- 8
- Tetanus, diphtheria and other toxin-producing bacterial infection of central nervous system
- 1. Introduction
- 2. Tetanus
- 2.1 Epidemiology
- 2.2 Causative agent
- 2.3 Pathogenesis
- 2.4 Clinical manifestations
- 2.5 Localized tetanus
- 2.6 Cephalic tetanus
- 2.7 Generalized tetanus
- 2.8 Neonatal tetanus
- 2.9 Diagnosis
- 2.10 Treatment
- 3. Diphtheria
- 3.1 Epidemiology
- 3.2 Causative agent
- 3.3 Pathogenesis
- 3.4 Clinical manifestations
- 3.5 Diagnosis
- 3.6 Treatment
- 4. Botulism
- 4.1 Epidemiology
- 4.2 Causative agent
- 4.3 Pathogenesis
- 4.4 Clinical manifestation
- 4.5 Foodborne botulism
- 4.6 Wound botulism.